Glucose Monitoring Global Market - Forecast to 2023

Published by IQ4I on 12th June 2017 | Ref: 1005257 | This Report Is In Stock

$4950 | Single User
$6750 | Site License
$9000 | Enterprise License
$4950 | Single User
$6750 | Site License
$9000 | Enterprise License

Introduction

Glucose Monitoring consist of products that are essential for patients suffering diabetes. With the projected rise in aged population and awareness about such conditions, the market is focused on growing with newer technology and improved products. According to IQ4I analysis, the Glucose Monitoring global market is expected to grow at single digit CAGR to reach ,248.5 million by 2023. Factors driving the Glucose Monitoring market are global rise in the prevalence and incidence of diabetes, continuous technological advancement, increasing demand for less invasive products, and increase in R&D investments are driving the market growth. Increase in obesity population due to lifestyle changes, increase in urbanization, untapped markets like Middle East, Africa shows that glucose monitoring market has vast opportunities in the coming years. Frequent product recalls i.e. glucose testing strips due to manufacturing defects or supply of expired test strips and less product differentiation among the self blood glucose monitors are the factors that are restraining the market growth. The limited reimbursement facilities and alternative treatments that include cell based assays, biomarkers identification and artificial pancreas and high cost associated with Continuous Glucose Monitoring (CGM) are threats for the market growth.

Glucose Monitoring global market is classified based on products, sample type, end-users and geography. The products segment is divided into three segments i.e., Invasive, Non-Invasive and lab based glucose monitoring products. The Invasive glucose monitoring products segment accounted the largest share in 2016 due to technological advancements, easy use, patient friendly etc. Invasive products are classified into Self glucose monitoring and continuous glucose products. The self glucose monitoring segment accounted the largest share in 2016 due to development of minimally invasive products. The Self glucose monitoring products are further classified into blood glucose monitors, blood glucose test strips, lancets and others. The blood glucose testing strips segment accounted for the largest share in 2016 due development of no coding strips. The continuous glucose monitoring market includes sensors/receiver and transmitter. The continuous glucose market includes products sensors/receiver and transmitter. Continuous glucose segment is fastest growing segment and is projected to grow at a strong CAGR of XX% from 2016 to 2023.

Based on sample type the market is segmented into blood, urine and others. The blood segment accounted the largest share in 2016 and is projected to grow at a CAGR of 0.3% from 2016 to 2023 due to the accuracy of results. Other source based glucose monitoring segment is fastest growing segment and is projected to grow at a strong CAGR of XX% from 2016 to 2023 due to increases R & D investment, many product are CE approved and expected launch very soon in market.

Based on end users the market is segmented into hospitals, private clinics, home care and ambulatory settings. Among end-users, home care segment accounted for the largest share in 2016 and is projected to grow at a strong CAGR of X% from 2016 to 2023 due to availability of self blood monitor over the counter and ease in operating these monitors and thereby reduces dependence on any clinics for glucose check.

Based on geography the market is segmented into North America (U.S. and Others), Europe (Germany, France, U.K. and Others), Asia-Pacific (Japan, China, India and Others) and Rest of the World (Brazil, Middle East & others and Rest of Latin America). North America accounts for the highest market share of XX% followed by Europe. The steep rise in aging population, advancement in technology, awareness of people about treatment options and favorable government policies are driving factors of glucose monitoring market. However, Asian countries especially India and China are the fastest growing regions with its growing demand for glucose monitoring products.

Major players in Glucose monitoring market include Roche (Switzerland), Dexcom (U.S.), B. Braun Melsungen AG (Germany), Medtronic, Inc. (Ireland), Johnson & Johnson (U.S.), Abbott Laboratories (U.S.), AgaMatrix (U.S.), Arkray (Japan), Ascensia (Switzerland), Trividia Health, Inc (U.S.) etc.

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

• North America

o U.S.

o Others

• Europe

o Germany

o U.K.

o France

o Others

• Asia-Pacific

o Japan

o China

o India

o Others

• Rest of the World (RoW)

o Brazil

o Rest of Latin America

o Middle-East (Middle East & Others)

Table of Contents

1 EXECUTIVE SUMMARY 27

2 INTRODUCTION 33

2.1 KEY TAKEAWAYS 33

2.2 REPORT DESCRIPTION 34

2.3 MARKETS COVERED 36

2.4 STAKEHOLDERS 37

2.5 RESEARCH METHODOLOGY 38

3 MARKET ANALYSIS 47

3.1 INTRODUCTION 47

3.2 MARKET SEGMENTATION 48

3.3 FACTORS INFLUENCING MARKET 50

organizations like FDA and others. 58

3.4 REGULATORY AFFAIRS 59

3.5 REIMBURSEMENT SCENARIO 62

3.6 PATENT ANALYSIS 69

3.7 TECHNOLOGY ADVANCEMENTS 71

3.8 UPCOMING TECHNOLOGY AND PRODUCT LAUNCH 74

3.9 FUNDING SCENARIO 86

3.10 GLUCOSE MONITORING - DEALS 88

3.11 CLINICAL TRIAL DATA 90

3.12 PORTER’S FIVE FORCE ANALYSIS 93

3.13 SUPPLY CHAIN ANALYSIS 97

3.14 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 102

4 GLUCOSE MONITORING GLOBAL MARKET, BY PRODUCTS 113

4.1 INTRODUCTION 113

4.2 INVASIVE GLUCOSE MONITORING 117

4.3 SELF GLUCOSE MONITORING 122

4.4 CONTINUOS GLUCOSE MONITORING 140

4.5 NON-INVASIVE GLUCOSE MONITORING 151

4.6 LAB BASED GLUCOSE MONITORING 173

5 GLUCOSE MONITORING GLOBAL MARKET, BY SAMPLE SOURCE 177

5.1 INTRODUCTION 177

5.2 BLOOD BASED GLUCOSE MONITORING 180

5.3 URINE BASED GLUCOSE MONITORING 183

5.4 OTHER SOURCES BASED GLUCOSE MONITORING 186

6 GLUCOSE MONITORING GLOBAL MARKET, BY END-USERS 190

6.1 INTRODUCTION 190

6.2 HOSPITALS 193

6.3 HOME CARE 197

6.4 PRIVATE CLINICS 200

6.5 AMBULATORY SETTINGS 203

7 REGIONAL ANALYSIS 206

7.1 INTRODUCTION 206

7.2 NORTH AMERICA 209

7.3 EUROPE 229

7.4 ASIA - PACIFIC 255

7.5 REST OF THE WORLD 281

8 COMPETITIVE LANDSCAPE 303

8.1 INTRODUCTION 303

8.2 APPROVALS 305

8.3 NEW PRODUCT LAUNCHES 309

8.4 AGREEMENTS, ACQUISITIONS & COLLABORATION 312

8.5 OTHER DEVELOPMENTS 314

9 MAJOR COMPANIES 319

9.1 ABBOTT LABORATORIES, INC 319

9.2 AGAMATRIX, INC. 328

9.3 ARKRAY, INC. 331

9.4 ASCENSIA DIABETES CARE HOLDINGS AG. 336

9.5 B.BRAUN MELSUNGEN AG 341

9.6 BIO-RAD LABORATORIES 348

9.7 DEXCOM INC. 355

9.8 JOHNSON & JOHNSON 362

9.9 MEDTRONIC, PLC 369

9.10 TRIVIDIA HEALTH, INC. 377

9.11 ROCHE HOLDINGS AG 381

Additional Details

Publisher

IQ4I

Publisher Information

Reference

1005257 |

Number of Pages

390

Report Format

PDF

This report is published by IQ4I

Download Free Report Summary PDF

Glucose Monitoring Global Market - Forecast to 2023 [Updated: 12-06-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.